↓ Skip to main content

Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced…

Overview of attention for article published in Journal for Immunotherapy of Cancer, January 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
13 news outlets
blogs
1 blog
twitter
24 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
24 Mendeley